Everstone Capital Invests $270 Million in Apothecon Group (Apothecon Pharmaceuticals and Navinta)
April 14, 2026
Singapore-headquartered private equity firm Everstone Capital has invested close to $270 million for a substantial stake in Apothecon Group, formed by India-based Apothecon Pharmaceuticals and US-based Navinta. Everstone said it will accelerate the group’s product pipeline, expand commercial reach into new geographies, and pursue complementary acquisitions, while the founding promoters will retain meaningful ownership.
- Buyers
- Everstone Capital
- Targets
- Apothecon Pharmaceuticals Private Limited, Navinta III Inc., Apothecon Group
- Sellers
- Apothecon founding promoters (Dr. Mahendra Patel and Joe Renner) (retaining a meaningful stake)
- Industry
- Pharmaceuticals
- Location
- Gujarat, India
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.